Mikael Tranholm Selected Research

Mikael Tranholm Research Topics

10	Hemorrhage 01/2021 - 02/2003
6	Hemophilia A (Haemophilia) 03/2013 - 11/2003
4	Disseminated Intravascular Coagulation 08/2011 - 09/2009
3	Thrombosis (Thrombus) 08/2011 - 09/2010
1	Neoplasms (Cancer) 01/2012
1	Carcinoma (Carcinomatosis) 01/2012
1	Disease Progression 01/2012
1	Hemophilia B (Haemophilia B) 08/2011
1	Hypovolemia 11/2010
1	Thrombocytopenia (Thrombopenia) 02/2003

5	recombinant FVIIa (rFVIIa)FDA Link 07/2012 - 02/2003
4	Dacarbazine (DIC)FDA LinkGeneric 08/2011 - 09/2009
2	Factor VII (Proconvertin)IBA 12/2011 - 02/2003
2	Factor VIIa (Activated Factor VII)IBA 08/2011 - 11/2003
2	Hemostatics (Antihemorrhagics)IBA 11/2010 - 11/2003
2	Thromboplastin (Tissue Factor)IBA 10/2010 - 01/2009
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Factor VIII (Coagulation Factor VIII)IBA 03/2013
1	vatreptacog alfaIBA 07/2012
1	fibrin fragment D (D-dimer)IBA 01/2012
1	Fibrinogen (Factor I)FDA Link 01/2012
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 08/2011
1	Starch (Cornstarch)IBA 11/2010
1	NN1731IBA 11/2010
1	Colloids (Colloid)IBA 11/2010
1	Thrombin FDA Link 10/2010
1	AntithrombinsIBA 10/2010
1	Fibrin Fibrinogen Degradation ProductsIBA 10/2010
1	Heparin (Liquaemin)FDA LinkGeneric 05/2008
1	AntibodiesIBA 02/2003

1	Intravenous Administration 08/2011
1	Therapeutics 08/2011
1	Hemodilution 11/2010
1	Platelet Transfusion (Blood Platelet Transfusions) 02/2003